Vladimir Ponomarev Selected Research

drozitumab

9/2017	Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
12/2014	Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir Ponomarev Research Topics

Disease

41	Neoplasms (Cancer) 08/2023 - 01/2002
9	Breast Neoplasms (Breast Cancer) 04/2017 - 01/2008
6	Neoplasm Metastasis (Metastasis) 09/2017 - 01/2008
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 12/2016
4	Hypoxia (Hypoxemia) 09/2017 - 11/2007
4	Osteolysis 01/2017 - 03/2009
4	Glioma (Gliomas) 08/2009 - 04/2003
3	Osteosarcoma (Osteogenic Sarcoma) 09/2017 - 05/2009
3	Carcinoma (Carcinomatosis) 03/2010 - 01/2008
2	Brain Injuries (Brain Injury) 01/2023 - 10/2022
2	Necrosis 01/2023 - 04/2017
2	Multiple Myeloma 01/2020 - 03/2009
2	Brain Neoplasms (Brain Tumor) 01/2018 - 04/2003
2	Bone Resorption 08/2014 - 03/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2023
1	Hemorrhage 01/2023
1	Inflammation (Inflammations) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 03/2017
1	Carcinogenesis 12/2016
1	Bites and Stings (Sting) 10/2015

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2023 - 07/2008
7	Chimeric Antigen ReceptorsIBA 09/2021 - 03/2017
5	ProdrugsIBA 09/2017 - 01/2002
5	LuciferasesIBA 03/2017 - 05/2004
4	LigandsIBA 08/2014 - 12/2007
4	fialuridineIBA 05/2007 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2007
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 10/2015
3	TH 302IBA 09/2017 - 02/2015
3	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 01/2008
3	EnzymesIBA 04/2017 - 01/2002
3	OsteoprotegerinIBA 08/2014 - 03/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 02/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2021 - 01/2018
2	Renilla LuciferasesIBA 09/2020 - 07/2008
2	drozitumabIBA 09/2017 - 12/2014
2	Zoledronic Acid (Zometa)FDA Link 01/2017 - 05/2009
2	Peptides (Polypeptides)IBA 10/2015 - 01/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 12/2014
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2014 - 03/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 03/2009
2	Fluorouracil (Carac)FDA LinkGeneric 01/2008 - 07/2004
2	fluorescent protein 583IBA 01/2008 - 04/2003
2	2'-fluoro-5-ethylarabinosyluracil (FEAU)IBA 05/2007 - 09/2004
2	Cytosine DeaminaseIBA 07/2004 - 01/2002
2	Thymidine KinaseIBA 04/2003 - 01/2002
1	Bevacizumab (Avastin)FDA Link 08/2023
1	Angiogenesis InhibitorsIBA 08/2023
1	GoldIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2020
1	Lactate Dehydrogenase 5IBA 09/2020
1	Internal Ribosome Entry SitesIBA 09/2020
1	Small Interfering RNA (siRNA)IBA 09/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020
1	B-Cell Maturation AntigenIBA 01/2020
1	Bispecific AntibodiesIBA 12/2019
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	DNA Repair EnzymesIBA 01/2018
1	HydrolasesIBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2018
1	isophosphamide mustard (IPAM)IBA 09/2017
1	azomycinIBA 09/2017
1	human TNFSF10 proteinIBA 09/2017
1	Heme (Haem)IBA 04/2017
1	Peroxidase (Myeloperoxidase)IBA 04/2017
1	CollagenIBA 04/2017
1	Eosinophil PeroxidaseIBA 04/2017
1	PeroxidasesIBA 04/2017
1	Adenosine Triphosphate (ATP)IBA 03/2017
1	LuciferinsIBA 03/2017
1	Programmed Cell Death 1 ReceptorIBA 03/2017
1	SpermineIBA 12/2016
1	Spermine SynthaseIBA 12/2016
1	Androgen Receptors (Androgen Receptor)IBA 12/2016
1	PolyaminesIBA 12/2016
1	Polyamine OxidaseIBA 12/2016
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 12/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2016
1	Monoclonal AntibodiesIBA 10/2015
1	EpitopesIBA 10/2015
1	HLA-A Antigens (HLA-A)IBA 10/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2015

Therapy/Procedure

15	Therapeutics 08/2023 - 01/2002
6	Immunotherapy 01/2022 - 12/2007
4	Cell Transplantation 09/2017 - 03/2009
2	Extracorporeal Membrane Oxygenation 01/2023 - 10/2022
2	Photochemotherapy (Photodynamic Therapy) 01/2023 - 02/2012
2	Radiotherapy 01/2018 - 01/2002
2	Drug Therapy (Chemotherapy) 02/2015 - 12/2014
1	Lasers (Laser) 01/2023
1	Precision Medicine 01/2023
1	Transplantation 03/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2015